- What Early Arthritis Looks Like in Dogs
- 8 Early Signs of Arthritis in Dogs
- Why the Early Signs Are So Easy to Miss
- The Four Stages of Canine Osteoarthritis
- Which Dogs Are at Highest Risk?
- What the Research Shows About Slowing Progression
- MoveGuard Adult: Built for the Maintenance Phase
- Frequently Asked Questions
What Early Arthritis Looks Like in Dogs
Canine osteoarthritis β the progressive deterioration of articular cartilage and surrounding joint tissue β develops silently. By the time most dog owners notice something is wrong, the condition has typically been developing for months or years. The earliest signs are behavioural rather than physical: a dog that was previously eager for walks but now hangs back, that takes longer to warm up after rest, that stops jumping into the car without encouragement. These are not personality changes or aging. They are pain-modifying behaviours β the dog is telling you the joints hurt, in the only language it has available. Recognising these early signals and acting on them is what separates management that preserves joint function from management that begins only when clinical lameness is obvious.
- Canine osteoarthritis (OA) affects an estimated 20% of dogs over one year of age and up to 80% of dogs over eight years β making it one of the most prevalent chronic conditions in dogs
- OA is progressive and irreversible once cartilage is lost β the goal of management is slowing progression and maintaining function, not reversal
- The earliest signs are almost always behavioural: reduced enthusiasm, slower warm-up after rest, subtle gait changes β not obvious lameness
- Large and giant breed dogs develop OA earlier and progress faster than small breeds because of higher lifetime joint loading and the legacy of developmental orthopaedic conditions from the growth window
- Body weight is the single most modifiable risk factor for OA progression: every kilogram above optimal body condition accelerates cartilage wear and worsens pain scores
- NSAIDs (anti-inflammatory medications) manage pain effectively but do not slow cartilage loss β a complete management approach includes both pain control and structural joint support
- The ingredients in MoveGuard Adult β glucosamine, chondroitin, NZ Green-Lipped Mussel, MSM, Eggshell Membrane β address both the inflammatory component and the cartilage maintenance component of OA management
8 Early Signs of Arthritis in Dogs
Post-rest stiffness that takes longer to resolve
The most consistent early sign β and the most missed. A dog with early OA will be noticeably stiff for the first several minutes after rising from rest, then gradually move more freely as synovial fluid warms and redistributes through the joint. In healthy adult dogs, this warm-up period is brief. As OA progresses, the stiffness period lengthens. Track it: time how long it takes your dog to walk normally after rising from overnight sleep. An increase over months is significant even if the stiffness itself seems mild.
Reluctance to climb stairs, jump, or get into the car
Activities that previously required no encouragement now produce hesitation, a shortened approach, or an outright refusal. The dog is not being stubborn β these activities require the sustained hip and knee extension or the impact of landing that produces pain in arthritic joints. A dog that used to bound into the car and now stands at the bumper waiting to be lifted is communicating joint pain clearly, in retrospect.
Reduced enthusiasm for walks or shortened self-selected distances
A dog with early OA will begin to self-regulate activity to manage pain β slowing pace on walks, stopping earlier than usual, lying down during play sessions that previously produced no fatigue. This is often misread as the dog "calming down with age." Age alone does not produce sudden reductions in activity drive in a three- or four-year-old dog. Pain does.
Subtle gait changes β shortened stride, slight head bob
Watch your dog walk from behind and from the side at a slow walk on a flat surface. A shortened rear stride (rear legs not reaching as far forward as the front legs), a slight asymmetry between left and right stride length, or a very subtle head bob (the head rises as weight comes off the painful leg) are early gait changes that predate obvious lameness by months. Video from behind at a walk is one of the most useful diagnostic tools you can give your vet.
Sleeping more, changing preferred sleeping positions
Dogs with joint pain sleep more as the body conserves energy and avoids the discomfort of sustained movement. They also change sleeping positions β moving away from their favourite spot if it requires a step or a jump to reach, or shifting from a curled-up position to a stretched-out position that requires less joint flexion. A dog that has moved from the bed to the floor, or from one room to another with different flooring, may be seeking a surface that is easier on the joints.
Irritability when touched around the affected joint
A dog that flinches, turns its head, or growls when touched around the hips, elbows, or spine β particularly if this is a new behaviour β is communicating localised pain. This is especially significant in a dog that was previously tolerant of handling. Pain changes temperament; a patient dog becoming touchy around specific body areas is a clinical signal.
Licking or chewing at a specific joint
Dogs lick and chew at areas of discomfort β not just wounds and itchy skin. A dog that repeatedly licks its elbow, a specific area of its flank, or the top of a paw may be responding to the deep ache of a developing arthritic joint beneath that area. This is distinct from allergic paw licking (which affects multiple paws and is accompanied by the characteristic yeasty odour and staining). Persistent focal licking at a joint area warrants veterinary assessment.
Visible muscle mass loss over the affected limb
Dogs with chronic joint pain unconsciously shift weight away from the painful limb β and the muscles of the less-used limb atrophy over weeks and months. Run both hands along the quadriceps of each rear leg and compare muscle bulk. Visible or palpable asymmetry between the two sides β in a dog that has not had an injury β is a strong indicator of chronic pain-related weight-shifting and warrants veterinary assessment to identify the underlying joint condition.
Most of these signs are subtle and intermittent early in OA. A written log of specific observations β with dates, duration, and circumstances β is far more useful to a veterinarian than "I think he's been a bit stiffer lately." Video clips of gait abnormalities, sleep position changes, and reluctance behaviours, logged over 4β8 weeks, transform a vague concern into a specific clinical picture. Most smartphone cameras capture gait at a slow walk clearly enough to be diagnostically useful.
Why the Early Signs Are So Easy to Miss
Three factors combine to make early canine OA nearly invisible until it has progressed significantly:
Dogs mask pain
Canine pain masking is an evolutionary adaptation β showing vulnerability in a pack-based species has survival costs, and dogs are wired to conceal discomfort until it becomes overwhelming. A dog with moderate joint pain will behave relatively normally in social situations, during excitement (the endorphin release of seeing a visitor or preparing for a walk temporarily masks chronic pain), and when observed by a veterinarian. The pain reveals itself in the quiet, daily moments: the hesitation before lying down, the slower morning rise, the shortened self-selected walk.
The signs are gradual and normalised
OA develops over months to years. Changes that would be obvious in retrospect are imperceptible week-to-week. An owner who sees their dog every day normalises the gradual reduction in enthusiasm, the slower warm-up, the new preference for the floor over the sofa. "He's just getting older" is the most common explanation β but a three-year-old Labrador that was running off-lead a year ago should not be "just getting older."
Obvious lameness is a late sign
By the time most dogs present with obvious, visible lameness β three-legged walking, consistent toe-touching, weight-bearing reluctance β the OA has been established for a significant period and secondary muscle atrophy has begun. The window for the most productive management intervention is the period before obvious lameness, not after. Waiting for lameness to act means waiting until the condition is already well-established.
The Four Stages of Canine Osteoarthritis
Subclinical OA
Microscopic cartilage changes without clinical signs. No visible lameness, no obvious pain. Detectable only by imaging. The target window for truly preventive intervention β before any clinical expression. Dogs that were managed well during the growth window and maintained at lean body condition enter this stage later and progress through it more slowly.
Mild OA β Early Clinical Signs
The 8 signs above begin to appear. Post-rest stiffness, subtle gait changes, reduced enthusiasm. No obvious lameness. This is the window the article is written for β the period when management intervention has its highest impact on progression rate. Diagnosis at this stage typically requires veterinary examination + radiography.
Moderate OA β Consistent Signs
Lameness is now consistent and multi-session. Exercise intolerance is established. Muscle atrophy may be visible. The dog has developed consistent compensatory movement patterns. Radiographic changes are typically clearly visible. Medical management (NSAIDs, physiotherapy) usually begins at this stage in conjunction with nutritional support and weight management.
Severe OA β Significant Disability
Significant functional impairment. Persistent pain at rest, not just during movement. Severe muscle atrophy. Quality of life meaningfully affected. This stage requires multimodal pain management. It is the stage the goal of early intervention is to delay or prevent entirely β through weight management, appropriate exercise, and consistent joint supplementation in the years before this stage is reached.
Which Dogs Are at Highest Risk?
OA risk in adult dogs is elevated by:
- Breed and size. Large and giant breeds develop OA earlier than small breeds because of higher lifetime joint loading and because they are more likely to have had developmental orthopaedic conditions (hip dysplasia, elbow dysplasia, OCD) that accelerate cartilage loss. Labrador Retrievers, Golden Retrievers, German Shepherds, Rottweilers, and Bernese Mountain Dogs are among the highest-risk breeds by OA prevalence data.
- Prior developmental orthopaedic disease. A dog diagnosed with hip dysplasia, elbow dysplasia, or OCD during the growth window will develop secondary OA in the affected joint earlier and progress faster than a dog without those conditions. The growth window sets the baseline; the adult management determines the rate of progression from that baseline.
- Body weight. Overweight dogs develop OA earlier, progress faster, and have significantly worse pain scores at equivalent disease stages compared to lean dogs. The relationship between body weight and OA progression is dose-dependent β every kilogram above optimal body condition is a meaningful increase in joint loading across every step of the dog's lifetime.
- Prior joint injury. CCL (cruciate ligament) rupture, joint fracture, or significant soft tissue injury to a joint accelerates OA in that joint. Dogs with CCL repair have a high rate of OA in the operated knee within 2β3 years of surgery.
- High-activity working breeds. Dogs with high cumulative lifetime joint loading β working sheepdogs, sporting dogs, hunting dogs β accumulate cartilage wear faster than sedentary dogs. The answer is not inactivity (which has its own negative effects) but appropriate exercise and consistent joint maintenance supplementation.
Is Your Adult Dog Getting the Right Joint Support?
Take the free Dog Wellness Quiz β personalised recommendation based on your dog's breed, age, and life stage.
Take the Quiz βWhat the Research Shows About Slowing Progression
Canine OA is irreversible once established β lost cartilage does not regenerate. The goal of management is slowing progression and maintaining function for as long as possible. The evidence base for intervention covers several modalities:
Weight management β the strongest single intervention
Multiple controlled studies in dogs show that weight reduction in overweight dogs with OA produces significant improvements in pain scores, mobility, and veterinarian-assessed lameness grading β sometimes comparable to NSAID treatment. A landmark study in Labrador Retrievers showed that dogs maintained at lean body condition from puppyhood developed clinical OA significantly later than their free-fed littermates. Body weight is the single most modifiable risk factor for OA progression and the highest-leverage non-pharmacological intervention available.
Appropriate exercise β type and consistency matter
Sustained, low-impact consistent exercise maintains muscle mass (which supports and protects joints), maintains range of motion, and supports healthy synovial fluid production. Swimming and controlled leash walking are appropriate. High-impact, repetitive activities β sustained ball fetch with sharp directional changes, sustained running, jumping β accelerate articular surface wear in OA-affected joints. The principle is: keep the joint moving consistently at appropriate intensity, not resting it completely or loading it excessively.
Nutraceutical support β glucosamine, chondroitin, GLM
The evidence for glucosamine and chondroitin in canine OA is meaningful β multiple double-blinded trials in dogs with OA show improvements in pain scores, mobility, and joint function at therapeutic doses (1000mg glucosamine + 800mg chondroitin for adult maintenance). NZ Green-Lipped Mussel extract has the strongest evidence of any whole-food marine ingredient for canine OA management, with multiple RCTs demonstrating significant reductions in joint pain scores and gait abnormality. MSM provides anti-inflammatory support. Eggshell Membrane (ESM) contributes collagen, elastin, and glycosaminoglycans that support the structural components of adult joint tissue. See: Do Joint Supplements for Dogs Actually Work? What the Evidence Shows.
NSAID therapy when needed
Non-steroidal anti-inflammatory medications (Carprofen, Meloxicam, Grapiprant, and others) are the most effective pharmaceutical pain management for canine OA and are appropriate when pain is impacting quality of life. NSAIDs manage pain effectively but do not slow cartilage loss β they are the pain management layer, not the structural support layer. A complete management approach uses both.
MoveGuard Adult: Built for the Maintenance Phase
MoveGuard Adult is formulated for adult dogs with closed growth plates (25β75 lb) β specifically for the adult maintenance phase where the goal shifts from supporting tissue formation (the growth window) to protecting and maintaining the tissue that has already formed.
Eight individually-disclosed actives at adult therapeutic maintenance doses: Glucosamine (1000mg) β the full adult cartilage matrix substrate dose. Chondroitin (800mg) β cartilage-degrading enzyme inhibition at adult maintenance dose. MSM (800mg) β sustained anti-inflammatory support. NZ Green-Lipped Mussel (300mg) β the highest GLM dose of either MoveGuard formula, reflecting the adult joint's higher ongoing anti-inflammatory support need. Eggshell Membrane (150mg) β collagen, elastin and glycosaminoglycans for adult structural joint support. Vitamin C (75mg) β higher adult collagen maintenance dose. Vitamin E (35 IU). Hyaluronic Acid (25mg) β adult synovial fluid maintenance.
For adult large breed dogs showing early OA signs, MoveGuard Adult provides the structural joint support layer that NSAID therapy alone does not address. For dogs not yet showing signs, it provides the preventive nutritional maintenance that slows the progression toward clinical OA. See: MoveGuard Growth vs MoveGuard Adult: Which Does Your Dog Need?
The most productive period to begin managing canine OA is Stage 2 β when the first subtle signs appear but before clinical lameness establishes. This is the window when weight management, appropriate exercise, and consistent joint supplementation have their highest impact on progression rate. Most dogs that present with advanced OA had the earliest signs for 12β24 months before they were recognised and acted on. The eight signs in this article are the signals to act on β not to monitor and revisit later.
"Our Labrador Retriever anticipates his MoveGuard chew every morning like it's a treat. After five weeks we could see a real difference in how quickly he gets going after waking up. Results by week 4, subscription locked in before the jar was finished."
β Verified MoveGuard customer"Started as a skeptic. Stayed because our Alaskan Malamute's joint health has been exceptional at every vet check since we started MoveGuard. Now I recommend it to every large breed owner I meet β don't wait until there's a problem."
β Verified MoveGuard customerAdult Maintenance Doses. Adult Joint Goals. On the Label.
MoveGuard Adult β 8 actives including 1000mg Glucosamine, 300mg NZ GLM, and Eggshell Membrane. Vet-reviewed. GMP/NSF certified. 60-Day Guarantee.
Shop MoveGuard Adult βFrequently Asked Questions
The earliest signs are almost always behavioural rather than physical: post-rest stiffness that takes longer to resolve, reluctance to climb stairs or jump, reduced enthusiasm for walks, subtle gait changes (shortened stride, slight asymmetry), sleeping more, and irritability when touched around specific joints. Obvious lameness is a late sign β by the time it appears, OA has typically been present for months or years.
Canine osteoarthritis can develop at any age β dogs with hip or elbow dysplasia from the growth window may show early OA signs from 2β3 years old. Large breed dogs generally begin showing early clinical OA signs from 5β7 years onward without prior developmental disease, and from 2β4 years if they had significant developmental orthopaedic conditions. OA affects an estimated 20% of dogs over one year and up to 80% of dogs over eight years.
OA is irreversible once cartilage is lost, but progression can be significantly slowed. The most evidence-supported interventions are: maintaining lean body condition (weight management has the strongest single impact on OA progression), appropriate consistent low-impact exercise, and joint supplementation with glucosamine, chondroitin, and NZ Green-Lipped Mussel at therapeutic doses. NSAIDs manage pain effectively but do not slow cartilage loss and are the pain control layer, not the structural support layer.
MoveGuard Adult is a joint supplement formulated for adult dogs with closed growth plates (25β75 lb). It provides eight individually-disclosed actives at adult therapeutic maintenance doses: Glucosamine 1000mg, Chondroitin 800mg, MSM 800mg, NZ Green-Lipped Mussel 300mg, Eggshell Membrane 150mg (collagen, elastin & glycosaminoglycans), Vitamin C 75mg, Vitamin E 35 IU, and Hyaluronic Acid 25mg. These support both the inflammatory component and the cartilage maintenance component of adult joint health.
MoveGuard Adult is for dogs with closed growth plates in the 25β75 lb range. If your dog is still growing (8β30 months depending on breed size), choose MoveGuard Growth instead. If your dog is a grown adult with confirmed closed plates, MoveGuard Adult provides the full adult therapeutic maintenance doses that a growth-phase formula does not. See: MoveGuard Growth vs MoveGuard Adult.
Related Reading
- How to Tell If Your Dog Is in Joint Pain: 10 Signs Owners Miss
- Do Joint Supplements for Dogs Actually Work? What the Evidence Shows
- MoveGuard Growth vs MoveGuard Adult: Which Does Your Dog Need?
- 6 Best Joint Supplements for Adult Dogs Compared (2026)
- Signs of Hip Dysplasia in Dogs: What to Watch For
- What Is Canine Hip Dysplasia? Causes, Symptoms, Stages and Treatment
- When to Switch From MoveGuard Growth to Adult
- Glucosamine for Dogs: How It Works and Dosage
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your veterinarian if your dog is showing signs of joint pain or mobility changes. This article is for informational purposes only and does not constitute veterinary advice or a recommendation for specific medical treatment.
